Conduit Pharmaceuticals Inc. (CDT), Thursday announced a deal with Sarborg Ltd., agreeing to enhance drug development by leveraging artificial intelligence and cybernetics platform.
Through this partnership, the San Diego-based company expects to enhance efficiency, reduce costs, and accelerate timelines by minimizing human intervention, and eventually optimizing the drug development cycle.
During the pre-market hours, Conduit's stock is moving up 23.90 percent, to $0.11 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.